Researchers identify an immunotherapy target to combat glioblastomas
Immune cells positive for a protein, S100A4 (in green) could be a potential therapeutic target for restoring antitumor action of immune cells toward glioblastomas. Credit: Houston Methodist Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and most common…
bubmagApril 6, 2022